SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-23-000776
Filing Date
2023-07-24
Accepted
2023-07-24 16:33:58
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss2314646_sc13d.htm SC 13D 90901
2 JOINT FILING AGREEMENT ss2314646_ex9901.htm EX-99.1 5499
  Complete submission text file 0000947871-23-000776.txt   97941
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Subject) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94123 | Film No.: 231105412
SIC: 2836 Biological Products, (No Diagnostic Substances)